A summary on non-viral systems for gene delivery based on natural and synthetic polymers

被引:36
|
作者
Sarvari, Raana [1 ,2 ]
Nouri, Mohammad [3 ]
Agbolaghi, Samira [4 ]
Roshangar, Laila [1 ]
Sadrhaghighi, Amirhouman [5 ]
Seifalian, Alexander M. [6 ]
Keyhanvar, Peyman [1 ,7 ,8 ,9 ]
机构
[1] Tabriz Univ Med Sci, Stem Cell Res Ctr, Tabriz, Iran
[2] Tabriz Univ Med Sci, Stem Cell & Regenerat Med Inst, Tabriz, Iran
[3] Tabriz Univ Med Sci, Fac Adv Med Sci, Dept Reprod Biol, Tabriz, Iran
[4] Azarbaijan Shahid Madani Univ, Fac Engn, Chem Engn Dept, Tabriz, Iran
[5] Tabriz Univ Med Sci, Fac Dent, Dept Orthodont, Tabriz, Iran
[6] London Innovat Bio Sci Ctr, Nanotechnol & Regenerat Med Commercializat Ctr Lt, London, England
[7] Tabriz Univ Med Sci, Sch Adv Med Sci, Dept Med Nanotechnol, Tabriz, Iran
[8] Univ Sci Educ & Res Network USERN, Convergence Knowledge Technol & Soc Network CKTS, Tabriz, Iran
[9] ARTAN110 Startup Accelerator, Tabriz, Iran
关键词
Gene delivery; gene therapy; natural polymer; synthetic polymer; vector; HIGH TRANSFECTION EFFICIENCY; ENDOTHELIAL GROWTH-FACTOR; GLYCOL)-MODIFIED GELATIN NANOPARTICLES; SELF-ASSEMBLED NANOPARTICLES; IN-VITRO; SIRNA DELIVERY; PLASMID DNA; MESSENGER-RNA; REDV PEPTIDE; POLYAMIDOAMINE DENDRIMER;
D O I
10.1080/00914037.2020.1825081
中图分类号
TB3 [工程材料学]; R318.08 [生物材料学];
学科分类号
0805 ; 080501 ; 080502 ;
摘要
Gene delivery systems necessitate the gene therapy, which is a unique approach for applying the tunable genes to treat any diseases. To tackle down the disadvantages of viral vectors like high cost, poor target cell specificity, and inability in transferring the large size genes, the non-viral vectors/carriers have been introduced for achieving better efficacy in gene therapy. A variety of carriers including liposomes, metallic/polymeric nanoparticles, dendrimers, gelatins, quantum dots/rods, etc. has been depicted distinct features in the gene therapy. Herein, the advances and applications of natural/synthetic polymeric carriers have been summarized in gene therapy and disadvantages/challenges have been also discussed.
引用
收藏
页码:246 / 265
页数:20
相关论文
共 50 条
  • [21] Novel nanostructured calcium phosphate based delivery systems for non-viral gene delivery
    Olton, Dana
    Lee, Dong Hyun
    Sfeir, Charles
    Kumta, Prashant N.
    PROCEEDING OF THE ASME SUMMER BIOENGINEERING CONFERENCE - 2007, 2007, : 1001 - 1002
  • [22] Non-viral gene delivery into primary natural killer lymphocytes
    Uhrberg, Markus
    Schoenberg, Kathrin
    Weinhold, Sandra
    Trompeter, Hans-Ingo
    FASEB JOURNAL, 2006, 20 (14): : 2660 - 2660
  • [23] Gene delivery systems: viral vs. non-viral vectors
    Kataoka, K
    Harashima, H
    ADVANCED DRUG DELIVERY REVIEWS, 2001, 52 (03) : 151 - 151
  • [24] Non-viral is superior to viral gene delivery
    Li, Shyh-Dar
    Huang, Leaf
    JOURNAL OF CONTROLLED RELEASE, 2007, 123 (03) : 181 - 183
  • [25] Cationic polymers for non-viral gene delivery to human T cells
    Olden, Brynn R.
    Cheng, Yilong
    Yu, Jonathan L.
    Pun, Suzie H.
    JOURNAL OF CONTROLLED RELEASE, 2018, 282 : 140 - 147
  • [26] Controllable gene therapy - Pharmaceutics of non-viral gene delivery systems
    Tomlinson, E
    Rolland, AP
    JOURNAL OF CONTROLLED RELEASE, 1996, 39 (2-3) : 357 - 372
  • [27] Non-viral Delivery Systems for Breast Cancer Gene Therapy
    Vaseghi, Golnaz
    Rafiee, Laleh
    Javanmard, Shaghayegh Haghjooy
    CURRENT GENE THERAPY, 2017, 17 (02) : 147 - 153
  • [28] Cyclodextrins in non-viral gene delivery
    Lai, Wing-Fu
    BIOMATERIALS, 2014, 35 (01) : 401 - 411
  • [29] How to screen non-viral gene delivery systems in vitro?
    van Gaal, Ethlinn V. B.
    van Eijk, Roel
    Oosting, Ronald S.
    Kok, Robbert Jan
    Hennink, Wim E.
    Crommelin, Daan J. A.
    Mastrobattista, Enrico
    JOURNAL OF CONTROLLED RELEASE, 2011, 154 (03) : 218 - 232
  • [30] Synthesis of neoglycolipids for the development of non-viral gene delivery systems
    Shmendel', E. V.
    Maslov, M. A.
    Morozova, N. G.
    Serebrennikova, G. A.
    RUSSIAN CHEMICAL BULLETIN, 2010, 59 (12) : 2281 - 2289